- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03520621
The Role of Sulfur Amino Acids in Risk of Kwashiorkor
Study Overview
Detailed Description
Kwashiorkor is one of two categorizations of severe acute malnutrition, but its etiology remains unclear. Although kwashiorkor is found only where diets are low in quality protein, comparisons of total dietary protein of individual children with and without kwashiorkor has been inconclusive. This study aims to compare amino acid profiles of the diets, not just total protein.
Evidence has shown that children with kwashiorkor consistently have very low circulating levels of sulfur amino acids (cysteine and methionine). Typical staple foods in regions with endemic kwashiorkor are generally poor in sulfur amino acids and the signs characterizing kwashiorkor can plausibly be explained by a shortage of sulfur amino acids.
In eastern Democratic Republic of the Congo, certain populations have chronically higher prevalence of kwashiorkor than neighboring populations with similar livelihoods, religion, environment, language and ethnicity. This study will compare these two populations to understand what differences between them may explain the difference in prevalence.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
North Kivu
-
Goma, North Kivu, Congo, The Democratic Republic of the
- Restore Hope for Africa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- resident of the selected population
- in the appropriate age range
Exclusion Criteria:
- caregiver reports the child has an illness that has required treatment for at least 6 months
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
High Prevalence Population
Prevalence of kwashiorkor (as diagnosed by bipedal pitting edema) is >2% among children 36 to 59 months old in the population, in Murambi/Malehe Health Area of eastern Democratic Republic of the Congo
|
no intervention
|
Low Prevalence Population
Prevalence of kwashiorkor (as diagnosed by bipedal pitting edema) is <2% among children 36 to 59 months old in the population, in Murambi/Malehe Health Area of eastern Democratic Republic of the Congo
|
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary sulfur amino acid
Time Frame: one measure at one time point within three weeks of registration
|
mg of sulfur amino acid in the diet per kg of body weight
|
one measure at one time point within three weeks of registration
|
dietary sulfur amino acid above or below WHO estimated average requirement (EAR)
Time Frame: one measure at one time point within three weeks of registration
|
the total sulfur amino acid in the diet will be calculated from a diet recall this will be a bivariate measure, "1" if the SAA in the diet is above or "0" if below the WHO/FAO requirement for sulfur amino acid intake of 17mg of sulfur amino acids per kg of body weight per day |
one measure at one time point within three weeks of registration
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
calories and protein in diet per kg of body weight
Time Frame: one measure at one time point within three weeks of registration
|
intake of calories (kcal/kg body weight), digestibility adjusted protein - sum of (grams of protein per food item x digestibility of food item) per kg of body weight quality adjusted protein = digestibility adjusted protein in the diet x proportion of requirement of the limiting amino acid |
one measure at one time point within three weeks of registration
|
urinary sulfate
Time Frame: one measure at one time point within three weeks of registration
|
sulfate excreted in the urine, normalized to creatinine
|
one measure at one time point within three weeks of registration
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
urinary thiocyanate
Time Frame: one measure at one time point within three weeks of registration
|
thiocyanate excreted in the urine (ppm)
|
one measure at one time point within three weeks of registration
|
socio-environmental factors (use of a latrine, shelter description, feeding habits, household demographics, health history)
Time Frame: one measure at one time point within three weeks of registration
|
sanitation - does the child use a latrine, defecate in the woods/fields, defecate around the home shelter - materials used for the roof and walls, size of the home in square meters feeding habits - number of hot meals per day, number of feeding episodes per day household demographics - age and sex of all people who eat and sleep regularly at that homestead health history - illnesses in the past 30 days, previous diagnoses of malnutrition and type of malnutrition
|
one measure at one time point within three weeks of registration
|
physical measurements of the subject's body size
Time Frame: one measure at one time point within three weeks of registration
|
height to the nearest mm, weight to the nearest 100g, middle-upper arm circumference to the nearest mm, visual signs of kwashiorkor (edema, rough or darkened skin, friable lightened hair, distended abdomen, lethargy or irritability)
|
one measure at one time point within three weeks of registration
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel Maxwell, PhD, Tufts University, Friedman School
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1605004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kwashiorkor
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
Washington University School of MedicineKamuzu University of Health SciencesWithdrawnKwashiorkor | MarasmusMalawi
-
Washington University School of MedicineCompletedKwashiorkor | MarasmusMalawi
-
Academy of Nutrition and DieteticsHartford Hospital; University of New Mexico; Meals on Wheels Central TexasNot yet recruiting
-
Diego MorettiSwiss Federal Institute of Technology; Wageningen University and Research; St... and other collaboratorsCompletedMalnutrition; ProteinSwitzerland
-
International Centre for Diarrhoeal Disease Research...CompletedProtein MalnutritionBangladesh
-
University of HohenheimCompleted
-
University GhentInstitut de Recherche en Sciences de la Sante, Burkina Faso; Centre Muraz; University...CompletedSevere Acute Malnutrition | Kwashiorkor | Nutritional EdemaBurkina Faso
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States